Pathomechanismus des Morbus Crohn mit NOD-2 (CARD 15) Mutation: defiziente mukosale Defensinexpression bei intakter Zytokinexpression
Jan Wehkamp(Robert Bosch Hospital), EF Stange(Robert Bosch Hospital), Michael Weichenthal(Christian-Albrechts-Universität zu Kiel), Elke Schäffeler(Robert Bosch Hospital), Miriam Schlee(Robert Bosch Hospital), Klaus Fellermann(Apple (Israel)), Matthias Schwab(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), K Herrlinger(Robert Bosch Hospital), Andreas Stallmach(Jena University Hospital), JM Schröder(Christian-Albrechts-Universität zu Kiel), Sebastian Nuding(University Hospital in Halle), M. Schmidt(Robert Bosch Hospital), J Harder(Universitäts Hautklinik Kiel)
Cited by 0
Related Papers
A roadmap for graphene
|Nature|2012|9.1k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969